个性化文献订阅>文章检索

文章名     作者     期刊名     摘要     卷     期         如果没有找到您所需要的文献，请点击 ——此处申请     共9条记录   Cisplatin Overdose Toxicities and Management [作者：Tsang, RY; Al-Fayea, T; Au, HJ,期刊：Drug safety, 页码：1109-1122 , 文章类型： Review，,卷期：2009年32-12] Cisplatin is one of the most widely used antineoplastic agents in the treatment of solid tumour and haematological malignancies, including cancers of the testes, ovary, bladder, head and neck, oesophagus, stomach and lun... Benefit-Risk Assessment of Leflunomide An Appraisal of Leflunomide in Rheumatoid Arthritis 10 Years After Licensing [作者：Alcorn, N; Saunders, S; Madhok, R,期刊：Drug safety, 页码：1123-1134 , 文章类型： Review，,卷期：2009年32-12] Evidence is accumulating for the early sustained usage of disease-modifying anti-rheumatic drugs (DMARDs) in rheumatoid arthritis. Leflunomide was licensed for the treatment of rheumatoid arthritis in 1998. Postmarketing... Improving Follow-Up Rates in Spontaneous Adverse Drug Reaction Reporting Effectiveness of a Targeted Letter Used by a Regional Centre in the UK [作者：Anton, C; Cox, AR; Ferner, RE,期刊：Drug safety, 页码：1135-1140 , 文章类型： Article，,卷期：2009年32-12] Background: Spontaneous reports of suspected adverse drug reactions to regulatory bodies and market authorization holders are important in pharmacovigilance. Follow-up information, which can be difficult to obtain, is of... Safety and Quality Assessment of 175 Illegal Sexual Enhancement Products Seized in Red-Light Districts in Singapore [作者：Low, MY; Zeng, Y; Li, L; Ge, XW; Lee, R; Bloodworth, BC; Koh, HL,期刊：Drug safety, 页码：1141-1146 , 文章类型： Article，,卷期：2009年32-12] Background: In recent years, there has been increasing interest in the use of herbs and supplements as an alternative to drugs used for the treatment of erectile dysfunction, in order to enhance sexual performance. Over ... Messages about Black-Box Warnings A Comparative Analysis of Reports from the FDA and Lay Media in the US [作者：Yong, PL; Bigman, C; Flynn, DN; Mittermaier, D; Long, JA,期刊：Drug safety, 页码：1147-1157 , 文章类型： Article，,卷期：2009年32-12] Background: The US FDA and lay media are important sources of information for the public about the risks of adverse events associated with drugs, yet the quality of FDA and US lay media reports about medication 'black-bo... The General and Comparative Efficacy and Safety of Duloxetine in Major Depressive Disorder A Systematic Review and Meta-Analysis [作者：Gartlehner, G; Thaler, K; Hansen, RA; Gaynes, BN,期刊：Drug safety, 页码：1159-1173 , 文章类型： Article，,卷期：2009年32-12] Background: Second-generation antidepressants dominate the management of patients with major depressive disorder (MDD). Evidence on the general and comparative benefits and harms is still accruing. Objective: To systemat... Evaluation of Post-Authorization Safety Studies in the First Cohort of EU Risk Management Plans at Time of Regulatory Approval [作者：Giezen, TJ; Mantel-Teeuwisse, AK; Straus, SMJM; Egberts, TCG; Blackburn, S; Persson, I; Leufkens, HGM,期刊：Drug safety, 页码：1175-1187 , 文章类型： Article，,卷期：2009年32-12] Backgound: Since November 2005, an EU Risk Management Plan (EU-RMP) has had to be submitted as part of a marketing application for all new chemical entities in the EU. In the EU-RMP, the safety profile of the medicine ha... Laboratory Tests in the Clinical Risk Management of Potential Drug-Drug Interactions A Cross-Sectional Study Using Drug-Dispensing Data from 100 Dutch Community Pharmacies [作者：Geerts, AFJ; De Koning, FHP; De Smet, PAGM; Van Solinge, WW; Egberts, TCG,期刊：Drug safety, 页码：1189-1197 , 文章类型： Article，,卷期：2009年32-12] Background: Patient safety and the life cycle of a drug are negatively influenced by the still increasing occurrence of potential drug-drug interactions (DDIs). Clinical risk management of potential DDIs is required in p... Tomorrow's World [作者：Edwards, IR,期刊：Drug safety, 页码：1105-1108 , 文章类型： Editorial Material，,卷期：2009年32-12]